Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation.
about
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysisThe digestive tract as the origin of systemic inflammationFarnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivoThe bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitisFXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9.Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epitheliaThe Yin and Yang of bile acid action on tight junctions in a model colonic epithelium.Protective effects of nonionic triblock copolymers on bile acid-mediated epithelial barrier disruption.Voluntary wheel running exercise and dietary lactose concomitantly reduce proportion of secondary bile acids in rat feces.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure.The role of intestinal epithelial barrier function in the development of NEC.Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayersSystematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation.High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids.Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.Impaired Bile Acid Homeostasis in Children with Severe Acute Malnutrition.Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling.Baicalein induces CD4(+)Foxp3(+) T cells and enhances intestinal barrier function in a mouse model of food allergy.Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice.Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1).Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia.The bile acid TGR5 membrane receptor: from basic research to clinical application.Bile acid malabsorption in inflammatory bowel disease.Formulations of deoxycholic for therapy: a patent review (2011 - 2014).Chenodeoxycholic acid requires activation of EGFR, EPAC, and Ca2+ to stimulate CFTR-dependent Cl- secretion in human colonic T84 cells.Characterization of V. cholerae T3SS-dependent cytotoxicity in cultured intestinal epithelial cells.Adherent-invasive Escherichia coli target the epithelial barrier.Physiological concentrations of bile acids down-regulate agonist induced secretion in colonic epithelial cells.Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF ratsCampylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion.Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.Arctigenin from Fructus Arctii (Seed of Burdock) Reinforces Intestinal Barrier Function in Caco-2 Cell Monolayers.Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms.
P2860
Q24635181-7CD7E212-7E24-4B5E-A2B2-4C013E80922EQ28076873-2F250B60-6AD4-47B1-965C-5AE8CD1497A6Q28296042-2C5BB6DE-05BE-4A0F-82F6-C8E69D7066A0Q28590901-AC7B4CD9-C810-442E-93BE-559FAD14A413Q30488268-CFE11BBE-131F-4CA1-9A8F-0C9AE90546F8Q33497020-7B0C605E-14D2-4E21-B637-D4A6BF1EF573Q33740929-25B66DDE-55F7-4C88-84AC-725C94241587Q34027222-6F115C3E-1B9B-4237-92D7-188F0D6E5B7BQ34125062-2C88ABB5-71C1-40CB-AEA1-1D0A2D9352EAQ34425909-3A463B54-2B25-4514-ABE0-84F753CF2758Q34612493-41ED5EDA-2C2A-4C0F-83D3-A8F98CD7D577Q34813587-BC6EDFDC-E9C9-426E-B7D4-F1C379FE202FQ35318848-0D9DB4B7-1B82-4E58-B8E6-68E81236CDB3Q35627444-AAF706D6-E32B-4CE3-911E-55E0E235B1DCQ35724871-E1C23C12-9A87-413E-B930-9C7C66DA22DBQ35783889-1AF9DA54-5E5E-46A6-B52E-EAC39B957943Q35813480-DDA4447D-A158-44E3-9B92-2BF1E5B22A4FQ35817782-2DD880B2-0C5E-439B-A6DA-32A1D21CF985Q35824398-6524F2E3-E4DC-4163-A435-63D41891492BQ36013380-AB02B7B7-123E-4F95-9401-38A178AB549BQ36023779-F8AFAF89-216D-477B-A161-CFF2639614BBQ36480407-D73C01D8-977B-4798-8D58-764C35CA2D41Q37208933-A319065F-F490-43D3-BB2B-FBB2A7765C28Q37443636-0C4B9B7A-5F31-4616-9D48-C4FA51319E52Q37474599-55106769-631A-4509-AC06-789867C1679AQ37677101-CA3AD6F7-E431-4A90-B38A-FE7CA9F1A705Q37890253-302FF47A-A898-4995-BE5B-3DA8864AF9D1Q38020262-09A35FFB-676D-49B6-805B-989715410062Q38177434-5C6E550F-489A-4450-953E-1D572A3DF200Q38253467-0587C3E4-75D7-4449-BB88-D083BBD1002EQ38612255-798DF518-53E5-4551-9B1D-6176B5066DDFQ38734395-A852662B-DE9F-431B-B569-0824FC691FD2Q38764395-F4B476F0-AF86-46D8-AC19-A316B8758066Q39782336-85192924-4361-474E-B064-9FBB62D87A5DQ39828074-0B8ED3E1-E2D4-4A5B-8D3E-254F5D50F80EQ39866527-89532290-4F53-48D2-9B38-F7028057AE75Q39954066-D27D1B67-174B-41B4-BF00-CCAA1CC8022EQ40752459-B30255D4-7078-45CC-ADF4-43F429718D79Q40917622-FA47B58C-EFB0-436B-829E-95F35170A4FDQ40958306-813563BF-616A-4311-BE61-B77F0DCEC82D
P2860
Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@ast
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@en
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@nl
type
label
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@ast
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@en
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@nl
prefLabel
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@ast
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@en
Bile acids modulate tight junc ...... onolayers via EGFR activation.
@nl
P2093
P2860
P356
P1476
Bile acids modulate tight junc ...... monolayers via EGFR activation
@en
P2093
Carmela Apicella
Francesco Raimondi
Maria Luisa Barretta
Merlin Nanayakkara
Pasquale Santoro
Roberto Paludetto
Serena Pappacoda
P2860
P304
P356
10.1152/AJPGI.00043.2007
P577
2008-01-31T00:00:00Z